Aminopeptidase A inhibitors

Bibliography

• WILK S, HEALY DP: Glutamyl aminopeptidase (aminopeptidase A), the BP-1/6C3 antigen. Adv. Neuroimmunol. (1993) 3:195–207.
   Google Scholar
• ••This is the first review of APA describing the purification, thephysical properties, the substrate specificity, the effect of metal ions (Ca2+ and Zn2+), the localisation of the enzyme, its biological role, the identity BP-1/6C3 antigen with the regulation of APA and its inhibition.
   Google Scholar
• WANG J, COOPER MD: Ilistidine residue in the zinc binding motif of aminopeptidase A is critical for enzymatic activity. Proc. Natl. Acad. Sci. USA (1993) 90:1222–1226.
   PubMedGoogle Scholar
• RAWLING ND, BARRETT AJ: Evolutionary families ofmetallopeptidases. Methods Enzymol. (1 9 9 5) 248:183–228.
   Google Scholar
• ZINI S, FOURNIE-ZALUSKI MC, CHAUVEL EN et al.: Identi- fication of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA (1996) 93:11968–11973.
   PubMed Web of Science ®Google Scholar
• ••Demonstration of the metabolic pathway of angiotensins inbrain by means of selective APA and APN inhibitors.
   Google Scholar
• CHANSEL D, CZEKALSKI S, VANDERMEERSCH S, et al: Characterization of angiotenin IV degrading enzymes and receptors on rat mesangial cells. Am. J. Physiol (1998) 275:535–542.
   Google Scholar
• THORSETT ED, WYVRATT MJ: Inhibition of zinc peptidases that hydrolyse neuropep tides. In: Neuropep-tides and their peptidases. Turner AJ (Ed.), Ellis Horwood Ltd. Chinchester, England (1987):229–292.
   Google Scholar
• REAUX A, FOURNIE-ZALUSKI M-C, ZINI S. et al.: Arninopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl. Acad. Sci. USA (1999) 96 (23) :13415–13420.
   PubMedGoogle Scholar
• ••Demonstration of the decrease in blood pressure ensured byinhibition of the tonic release of angiotensin III.
   Google Scholar
• MIGAUD M, DURIEUX C, CHAUVEL EN et al.: The in vivo metabolism of cholecystokinin (CCK8) is essentially ensured by aminopeptidase A. Peptides (1996) 17 (0601–607.
   PubMedGoogle Scholar
• NOBLE F, ROQUES BP: CCK-B receptor: chemistry, molecular biology biochemistry and pharmacology. Progress Neurobiol. (1999) 58:349–379.
   PubMed Web of Science ®Google Scholar
• •Review on brain CCK8, its metabolism and pharmacology.
   Google Scholar
• ROQUES BP, NOBLE F, DAUGE V, FOURNIE-ZALUSKI M-C, BEAUMONT A: Neutral endopeptidase 24.11: structure, inhibition and experimental and clinical pharma-cology. Pharmacol. Rev. (1993) 45:87–146.
   Google Scholar
• •Molecular mechanism of peptide bond hydrolysis by zinc metallopeptidases and strategies used in designing inhibitors.
   Google Scholar
• ROQUES BP: Novel approaches to targeting neuropep-tide systems. Trends Pharmacol Sci. (2000) 21:475–483.
   PubMed Web of Science ®Google Scholar
• LOJDA Z, GOSSRAU R: Study on aminopeptidase A. Histochemistry (1980) 67:267–290.
   PubMedGoogle Scholar
• ••This is a complete and systematic comparative biochemicaland histochemical investigation of the localisation of the enzyme in the cardiovascular, the digestive, the respiratory, the urogenital systems, the liver and lung, the endocrine, the central and peripheral nervous systems.
   Google Scholar
• ZINI S, MASDEHORS P, LENKEI Z et al.: Arninopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rat. Neurosci-ence (1997) 78 (4) :1187–1193.
   PubMedGoogle Scholar
• ••This is a more precise distribution of APA in rat brain nucleiusing microdissection.
   Google Scholar
• RAMIREZ MJ, MARTINEZ JM, PRIETO I, ALBA F, RAMIREZ M: Lateralization of aminopeptidase A activity in substantia nigra, striatum and frontal cortex of rats. Neuropeptides (1999) 33 (2) :155–158.
   PubMedGoogle Scholar
• WU Q, LI L, COOPER MD, PIERUS M, GORVEL JP: Aminopeptidase A activity in the murine B-lymphocytes differentiation antigen BP-1 /6 C3. Proc. Natl. Acad. Sci. USA (1991) 88:676–680.
   PubMedGoogle Scholar
• •Molecular identity between APA and BP-1/6C3.
   Google Scholar
• LI, L, WANG, J, COOPER, M.D. cDNA cloning and expres- sion of human glutamyl aminopeptidase (aminopepti-dase A). Genomics (1993) 17:657–664.
   PubMedGoogle Scholar
• •Sequence of APA.
   Google Scholar
• NANUS DM, ENGELSTEIN D, GASTL GA et al.: Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc. Natl. Acad. Sci. USA (1993) 90:7069–7073.
   PubMed Web of Science ®Google Scholar
• •Sequence of human APA and comparison with other zinc peptidases.
   Google Scholar
• WANG J, WALKER H, LIN Q et al.: The mouse BP-1 gene: structure, chromosomal localization and regulation of expression by Type I interferons and interleukin-7. Genomics (1996) 33:167–176.
   PubMed Web of Science ®Google Scholar
• VAZEUX G, WILK S, WILK E, CORVOL P, LLORENS-CORTES C: Production and properties of a recombi-nant soluble form of aminopeptidase A. Eur.J. Biochem. (1998) 254:671–678.
   PubMedGoogle Scholar
• •Removal of the transmembraneous sequence of APA. The soluble form has the same enzymatic properties that the WT enzyme.
   Google Scholar
• CHEUNG HS, CUSHMAN, DW: A soluble aspartate aminopeptidase from dog kidney. Biochem. Biophys. Acta (1971) 242:190–193.
   PubMed Web of Science ®Google Scholar
• KELLY JA, NEIDLE EL, NEIDLE A: An aminopeptidase from mouse brain cytosol that cleaves N-terminal amino acid residues. J. Neurochem. (1983) 40:1727–1734.
   PubMedGoogle Scholar
• WILK S, WILK E, MAGNUSSON RP: Purification, charac-terization and cloning of a cytosolic aspartyl aminopeptidase. J. Biol. Chem. (1998) 273 (26):15961–15970.
   PubMed Web of Science ®Google Scholar
• VAZEUX G, WANG J, COOPER M, CORVOL P, LLORENS-CORTES C: Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J. Biol. Chem. (1996) 271 (15)9069–9074.
   Google Scholar
• VAZEUX, G, ITURRIOZ, X, CORVOL, P, LLORENS-CORTES, C. A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochem. J (1997) 327 (3):883–889.
   Google Scholar
• LUCIANI N, MARIE-CLAIRE C, RUFFET E et al: Characteri-zation of G1u35° as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC.3.4.11.2): insights into its mechanism of action. Biochemistry (1998) 37(2):686–692.
   Google Scholar
• VAZEUX G, ITURRIOZ X, CORVOL P, LLORENS-CORTES C: A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A. Biochem. J (1998) 334:407–413.
   PubMedGoogle Scholar
• MATTHEWS BW: Structural basis of the action ofthermolysin and related zinc peptidases. Acc. Chem. Res. (1988) 21 :333–340.
   Web of Science ®Google Scholar
• MARIE-CLAIRE C, RUFFET E, TIRABOSCHI G, FOURNIE-ZALUSKI MC: Differences in transition state stabiliza-tion between thermolysin (EC 3.4.2 4.27) and neprilysin (EC 3.4.24.11). FEBSLett. (1998) 438:215–219.
   Google Scholar
• DANIELSON EM, NOREN 0, SJOSTROM TT, INGRAM J, KENNY AJ: Proteins of the kidney microvillar membrane. Aspar tate aminopeptidase: purification by immunoabsorbent chromatography and properties of the detergent- and proteinase-solubilized forms. Biochem. J. (1980) 189:591–603.
   Google Scholar
• ITURRIOZ X, VAZEUX G, CELERIER J, CORVOL P, LLORENS-CORTES C: Ilistidine 450 plays a critical role in catalysis and, with Ca2+, contributes to the substrate specificity of aminopeptidase A. Biochemistry (2000) 39(103061–3068.
   Google Scholar
• TOBE H, MORISHIMA H, NAGANAWA H et al: Structure and chemical synthesis of amastatin. Agrk. Biol. Chem. (1979) 43(3):591–596.
   Web of Science ®Google Scholar
• TOBE H, MORISHIMA T, AOYAGI T et al.: Synthesis and structure-activity relationships of amastatin analogues, inhibitors of aminopeptidase A. Agrk. Biol. Chem. (1982) 46(7):1865–1872.
   Web of Science ®Google Scholar
• TIEKU S, HOOPER NM; Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem. Pharmacol. (1992) 44:1725–1730.
   Google Scholar
• YOSHIDA S, NAKAMURA Y, NAGANAWA H, AOYAGI T, TAKEUCHI T:Probestin, a new inhibitor of aminopepti-dase M, produced by Streptomyces azureus MH663-2F6. II. Structure determination of probestin. Antibiol (1990) 43 (2) :149–153.
   Google Scholar
• NAGAI M, KOJIMA F, NAGANAWA H. et al: Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ71 6-m3. J. Antibiot. (1997) 50 (1):82–84.© Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (2001) 11(3)
   Google Scholar
• AOYAGI T, YOSHIDA S, MATSUDA N et al: lzuhistin, a new inhibitor of aminopeptidase M, produced by Bacillus laterosporus BMI156-14 F1 . I. Taxonomy, production, isolation, physico-chemical properties and biological activities. j Antibiol (1991) 44 (6):573–578.
   Google Scholar
• UMEZAWA H, AOYAGI T, OHUCHI S eta].: Arphamenine A and B, new inhibitors of aminopeptidase B, produced by bacteria. J. Antibiot. (1983) 36(10:1572–1575.
   Google Scholar
• CHUNG A, RYAN JW, BEIRYER P: Inhibition of theformation of angiotensin III. Adv. Exp. Med. Biol. (1983) 156:693–703.
   PubMedGoogle Scholar
• WILK S, THURSTON LS: Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids. Neuropeptides (1990) 16:163–168.
   PubMedGoogle Scholar
• CHAUVEL EN, CORIC P, LLORENS-CORTES C et al: Investigation of the active-site of aminopeptidase A using a series of new thiol- containing inhibitors. J Med. Chem. (1994) 37(9):1339–1346.
   PubMedGoogle Scholar
• CHAUVEL EN, LLORENS-CORTES C, CORIC P et al: Differ-ential inhibition of aminopeptidase A and aminopep-tidase N by new 13-amino thiols. J Med. Chem. (1994) 37 (18):2950–2957.
   PubMedGoogle Scholar
• ••A complete structure-activity investigation of the Si subsiteof APA leading to the first specific inhibitor of APA versus APN with an affinity in the 106–10 7 M range.
   Google Scholar
• KAZNADAR T, DAVID C, CRETE D et al : Arninopeptidase A involved in the inactivation of endogenous CCK8: a micro dialysis study. J. Neuropsychopharmacol. (1997) 11:A50.
   Google Scholar
• ZINI S, DEMASSEY Y, FOURNIE-ZALUSKI M-C et al: Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. Neuroreport (1998) 9:825–828.
   PubMed Web of Science ®Google Scholar
• •Demonstration of the role of angiotensin III on the regula-tion of plasma vasopressin release.
   Google Scholar
• LEJCZAK B, POPIEL DE, CHOSZAK M, KAFARSKI P: Inhibi-tion of aminopeptidases by phosphonic acid analogues of aspartic and glutamic acids. J Enz. Inh. (1993) 7:97–103.
   PubMed Web of Science ®Google Scholar
• DAVID C, BISCHOFF L, MEUDAL H et al: Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme. J Med. Chem. (1999) 42 (25):5197–5211.
   Google Scholar
• ••A complete characterisation of the three Si, Si' and Szt sub-sites of APA leading to the first nanomolar and subnano-molar inhibitors of the enzyme in the thiol series described to date.
   Google Scholar
• DAVID-BASEI C, BISCHOFF L, FOURNIE-ZALUSKI M-C, ROQUES BP: Synthesis of [[(25:3R):3-amino-2-sulfhydry1-5-sulfonate]-pentanoyll-L-34125IFiodo- tyrosine-L-aspartic acid: a radiolabelled inhibitor of aminopeptidase A. J. Lab. Comp. Radiopharm. (2001) 44:89–98
   Google Scholar
• •A compound for visualisation of APA.
   Google Scholar
• CHEN H, NOBLE F, MOTHE A et al.: Phosphinic deriva-tives as new dual enkephalin degrading enzyme inhibitors: synthesis, biological properties and antinociceptive activities. J. Med. Chem. (2000) 43 (7):1398–1408.
   PubMed Web of Science ®Google Scholar
• GEORGIADIS D, VAZEUX G, LLORENS-CORTES C, YIOTAKIS A, DIVE V. Potent and selective inhibition of zinc aminopeptidase A (EC 3.4.11.7, APA) by glutamyl aminophosphinic peptides: importance of glutamyl aminophosphinic residue in the P1 position. Biochem-istry (2000) 39 (5):1152–1155.
   Google Scholar
• •A study reporting nanomolar and subnanomolar inhibitors of APA in the phosphinic series
   Google Scholar
• LIN Q, TANIUCHI I, KITAMURA D et al: T and B cell development in BP-1 /6C3 /Aminopeptidase A-deficient mice. j linmunoi. (1998) 160:4681–4687.
   Google Scholar
• KUDA T, SHOJI M, ARAI H, KAWASHIMA S, SAIDO TC: Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease. Biochem. Biophys. Res. Commun. (1997) 231:526–530.
   PubMedGoogle Scholar
• FINSTAD CL, CORDON-CARDO C, BANDER NH et al: Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc. Nat. Acad. Sci. USA (1985) 82:2955–2959.
   PubMed Web of Science ®Google Scholar
• BOGENRIEDER T, FINSTAD CL, FREEMAN RH et al: Expression and localization of aminopeptidase A, aminopeptidase N and dipeptidyl peptidase W in benign and malignant human prostate tissue. The Prostate (1997) 33:225–232.
   PubMed Web of Science ®Google Scholar